C-type natriuretic peptides and methods thereof in treating cancer

MYPI2026002312A0Undetermined Publication Date: 2021-12-12PHARMAIN CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026002312
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-06-15
Filing Date
2021-06-11
Publication Date
2021-12-12
Patent Text Reader

Abstract

The present disclosure relates to methods of treating a subject having abnormal vasculature by administering to the subject a therapeutically effective bolus dose of a composition including a long acting C-type natriuretic peptide (CNP), CNP derivative, long acting CNP derivative, long acting CNP receptor (NPRB) agonist, or any combination thereof. The present disclosure further relates to treating a subject in need of an increase in cytotoxic T cell and / or NK cell activity by administering to the subject a therapeutically effective bolus dose of a composition including a long acting C-type natriuretic peptide (CNP), CNP derivative, long acting CNP derivative, long acting CNP receptor (NPRB) agonist, or any combination thereof. Fig. 20
Need to check novelty before this filing date? Find Prior Art